Geode Capital Management, LLC United Therapeutics Corp Transaction History

Geode Capital Management, LLC

  • $1.07 Trillion
  • Q1 2024

A detailed history of Geode Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 828,271 shares of UTHR stock, worth $228 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
828,271
Previous 779,762 6.22%
Holding current value
$228 Million
Previous $171 Million 10.97%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$210.76 - $249.51 $10.2 Million - $12.1 Million
48,509 Added 6.22%
828,271 $190 Million
Q4 2023

Feb 13, 2024
SELL
$214.88 - $256.94 $10.8 Million - $13 Million
-50,484 Reduced 6.08%
779,762 $171 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $5.06 Million - $5.92 Million
23,865 Added 2.96%
830,246 $188 Million
Q2 2023

Aug 11, 2023
BUY
$205.19 - $232.99 $9.69 Million - $11 Million
47,238 Added 6.22%
806,381 $178 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $20.9 Million - $27.1 Million
98,267 Added 14.87%
759,143 $170 Million
Q4 2022

Feb 13, 2023
BUY
$205.95 - $280.43 $6 Million - $8.17 Million
29,137 Added 4.61%
660,876 $184 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $1.07 Million - $1.29 Million
-5,274 Reduced 0.83%
631,739 $132 Million
Q2 2022

Aug 12, 2022
SELL
$174.81 - $241.14 $1.01 Million - $1.39 Million
-5,754 Reduced 0.9%
637,013 $150 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $19.6 Million - $25.3 Million
-118,181 Reduced 15.53%
642,767 $115 Million
Q4 2021

Feb 11, 2022
BUY
$184.32 - $216.08 $11.6 Million - $13.6 Million
62,882 Added 9.01%
760,948 $164 Million
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $2.11 Million - $2.52 Million
-11,713 Reduced 1.65%
698,066 $129 Million
Q2 2021

Aug 13, 2021
BUY
$170.47 - $211.93 $7.72 Million - $9.59 Million
45,260 Added 6.81%
709,779 $127 Million
Q1 2021

May 12, 2021
BUY
$153.94 - $174.85 $865,142 - $982,657
5,620 Added 0.85%
664,519 $111 Million
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $5.68 Million - $8.47 Million
55,777 Added 9.25%
658,899 $100 Million
Q3 2020

Nov 13, 2020
SELL
$99.9 - $121.13 $1.67 Million - $2.02 Million
-16,707 Reduced 2.7%
603,122 $60.9 Million
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $3.54 Million - $4.8 Million
38,141 Added 6.56%
619,829 $75 Million
Q1 2020

May 14, 2020
BUY
$79.39 - $115.35 $3.33 Million - $4.84 Million
41,999 Added 7.78%
581,688 $55.2 Million
Q4 2019

Feb 13, 2020
BUY
$78.31 - $95.34 $1.98 Million - $2.41 Million
25,241 Added 4.91%
539,689 $47.5 Million
Q3 2019

Nov 12, 2019
SELL
$74.85 - $85.99 $214,819 - $246,791
-2,870 Reduced 0.55%
514,448 $41 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $4.28 Million - $6.8 Million
-56,290 Reduced 9.81%
517,318 $40.4 Million
Q1 2019

May 14, 2019
SELL
$107.15 - $126.84 $2.36 Million - $2.79 Million
-22,007 Reduced 3.69%
573,608 $67.3 Million
Q4 2018

Feb 13, 2019
BUY
$101.4 - $128.73 $1.1 Million - $1.4 Million
10,863 Added 1.86%
595,615 $64.8 Million
Q3 2018

Nov 13, 2018
SELL
$113.81 - $129.46 $277,127 - $315,235
-2,435 Reduced 0.41%
584,752 $74.7 Million
Q2 2018

Aug 14, 2018
SELL
$101.14 - $118.31 $2.78 Million - $3.25 Million
-27,475 Reduced 4.47%
587,187 $66.4 Million
Q1 2018

May 15, 2018
SELL
$107.21 - $151.94 $7.58 Million - $10.7 Million
-70,697 Reduced 10.32%
614,662 $69 Million
Q4 2017

Feb 13, 2018
SELL
$118.58 - $151.28 $7.35 Million - $9.37 Million
-61,965 Reduced 8.29%
685,359 $101 Million
Q3 2017

Nov 14, 2017
BUY
$114.6 - $136.81 $5.43 Million - $6.49 Million
47,409 Added 6.77%
747,324 $87.6 Million
Q2 2017

Aug 14, 2017
BUY
N/A
699,915
699,915 $90.8 Million

Others Institutions Holding UTHR

# of Institutions
562
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $12.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email